The decrease in protein synthesis is further supported by the downregulation of JUNB, which plays a role in the positive regulation of transcription via RNA polymerase II and is also known to be involved in angiogenesis in various cancers, including multiple myeloma [33,34], breast cancer [35], and renal cell carcinoma [36]. Here, JUNB is linked to cancer.